H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)

July 3, 2025 6:46 AM UTC Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $118.00 price target on Disc Medicine (NASDAQ: IRON).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login